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and Refinement of animal testing), their beginnings, impact and 
development over the years as well as the introduction of ad-
ditional Rs such as Responsibility, Rehabilitation or Remember. 
Topics and strategies such as the use of “lower” animals, fewer 
animals, maximizing study outcome, animal sharing and welfare 
were discussed. Prof. Schneider closed his talk leading over to 
in silico methods including frameworks for high quality sci-
ence, planning experiments and power analysis over databases, 
visualization tools and data analysis procedures, prediction mod-
els, and quantitative structure-activity relationships. Susanna 
Röblitz (ZIB, FU, Berlin) presented the area of computational 
systems biology starting with the definition of a model, which 
differs between experimental, conceptual and mathematical 
models. Mathematical models are built to formalize human in-
terpretation. In accordance with the quote “A model should be 
as simple as possible but not any simpler” (Albert Einstein), it 
is important to achieve the right balance between simplicity and 
accuracy. Ordinary differential equations are used in systems bi-
ology, e.g., to describe kinetics. Since biological processes are 
non-linear, the models often exhibit non-obvious behavior. It 
is still a major challenge to estimate model parameters and to 
quantify the uncertainty of model predictions. Using an example 
(female menstrual cycle based on clinical data), she showed the 
A seminar and interactive workshop on “In silico Methods – 
Computational Alternatives to Animal Testing” was held in 
Berlin, Germany, organized by Annemarie Lang, Frank Butt-
gereit and Andrea Volkamer at the Charité-Universitätsmedizin 
Berlin, on August 17-18, 2017. During the half-day seminar, the 
variety and applications of in silico methods as alternatives to 
animal testing were presented with room for scientific discus-
sions with experts from academia, industry and the German fed-
eral ministry (Fig. 1). Talks on computational systems biology 
were followed by detailed information on predictive toxicology 
in order to display the diversity of in silico methods and the 
potential to embrace them in current approaches (Hartung and 
Hoffmann, 2009; Luechtefeld and Hartung, 2017). The follow-
ing interactive one-day Design Thinking Workshop was aimed 
at experts, interested researchers and PhD-students interested in 
the use of in silico as alternative methods to promote the 3Rs 
(Fig. 2). Forty participants took part in the seminar while the 
workshop was restricted to sixteen participants.
Seminar Report – Update on current 
developments from experts 
The seminar was opened by Marlon Schneider (Bf3R, BfR, 
Berlin) with an introduction on the 3Rs (Replacement, Reduction 
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power and complexity of these models needed to form virtual pa-
tient cohorts (Röblitz et al., 2013). Liesbet Geris (University of 
Liège, KU Leuven, Belgium) showed translational applications 
of in silico methods when combined with different aspects of 
tissue engineering. She presented the modelling of differentiation 
processes of mesenchymal stem cells or chondrocytes based on 
gene regulation by using Boolean models (Kerkhofs and Geris, 
2015; Kerkhofs et al., 2016) and explained that prediction mod-
els can support the development or validation of new carriers for 
bone formation (Kerckhofs et al., 2016) or support the design 
and optimization of cell culture bioreactors (Guyot et al., 2014; 
Papantoniou et al., 2014). The ongoing work and importance of 
the Virtual Physiological Human Initiative1 towards individual-
ized physiology-based computer simulations that aims to revolu-
tionize human medicine was also presented. Andrea Volkamer 
(Charité, BB3R, Berlin) introduced the focus area of predictive 
toxicology and its relevance for designing new, safe chemicals 
and drugs. The ever-growing amount of available compound tox-
icity data is being used to develop reliable methods for risk as-
sessment aiming towards transforming toxicology into a predic-
tive science and reducing animal testing. Beside the explanation 
of techniques such as read-across, structural alerts and QSAR/
machine learning, she focused on molecular fingerprint-based 
screening that is used to identify structural similarities and ul-
timately predict toxicity, outlined on the Tox21 challenge2 data. 
Joerg Wichard (Bayer AG, Berlin) presented the IMI eTOX 
(“Integrating bioinformatics and chemoinformatics approaches 
for the development of expert systems allowing the in silico pre-
diction of toxicities”) project that aimed at collecting high quality 
data from archives of different pharmaceutical companies within 
one database for data mining and in silico prediction. He pointed 
out the challenges of running this multi-stakeholder EU project 
(13 pharma companies + 7 academic institutions + 6 SMEs), 
including precompetitive data sharing and IP protection as well 
as the development of a controlled vocabulary and an ontology 
browser. Some internal examples of where the database/models 
helped to drive forward developments of a specific drug based 
on reported findings on similar compounds were shown. A demo 
database is open to the public and can be visited under http://
etoxsys.com/. The seminar closed with a short discussion round 
and summary.  
ReThink3R-Workshop – Implementation of 
in silico methods to promote the 3Rs
Design Thinking is a systematic approach to problem solving. It 
combines creative with analytical methods from different fields 
and helps exploit the intrinsic innovative potential of multi-
disciplinary teams. The Design Thinking process contributes 
to finding key questions, performing research with a focus on 
gaining empathy for the users, and designing a serious, realistic 
solution. Thus, important aspects of the process are interdisci-
plinary teamwork, “thinking outside the box”, a flexible work 
environment, visualization and empathy. 
The workshop, hosted by Annemarie Lang and Laura Behm, 
included sixteen participants, split into two teams each including 
experts, postdocs and PhD students. After an interactive warm-
up and team check-in, the central challenge was introduced to 
the participants: “Design a strategy to implement in silico meth-
ods in basic research to promote the 3Rs”. During the following 
understand-phase, the exploration of the complexity inherent to 
the challenge, including potential stakeholders/ target groups as 
well as possible problem areas, played a central role. Aspects that 
came up during the brain-storming phase were, e.g., a lack of 
knowledge and awareness of suitable in silico alternatives, a bias 
towards in vitro and in vivo, a lack of communication, time limi-









ibility. The observe-phase aimed at getting to know different per-
spectives and insights by interviewing different stakeholders and 
sharing the individual interview experience within the team. The 
participants prepared questions and went out in groups of two 
to interview people in the labs or on the campus. The synthesiz-
ing-phase revealed interesting aspects and problems. In essence, 
the participants identified i) a general discomfort of researchers 
to do animal testing, ii) a defensive attitude when the questions 
came to animal testing, iii) insecurity towards animal protection 
organizations, iv) a lack of knowledge and trust towards in silico 
methods and alternatives in general, v) limited willingness to talk 
about own scientific work, and vi) anger about burdens of animal 
experiment applications including the defense towards the 3Rs. 
Using different techniques, such as personas and problem state-
ments (defining a user with his/her need in a certain context), the 
gathered information was synthesized and a concrete underlying 
problem was specified (define-phase). Within the ideation-phase 
the participants got to know a number of playful approaches that 
help to brainstorm in a creative and effective manner. This phase 
was completed by choosing one of the ideas and transforming 
it into a prototype. In the breakout groups, two very different 
innovative prototypes were created: i) a “Science Match” app, 
enabling scientists from basic research to connect with experts 
from the in silico field based on matching interests and ii) a data 
analyzer including the opportunity to analyze big data to iden-
tify new aspects and hypotheses that were not obvious before and 
to produce a paper out of the merged data sets. The following 
testing-phase enabled the participants to test their prototypes with 
the coaches and observe their reactions. Since Design Thinking is 
iterative, intermediate solutions are also potential starting points 
for alternative paths, including redefining the initial problem and 
going back to former steps such as the observe-phase. A small 
final presentation of the prototypes was followed by a feedback 
round concerning the workshop. The overall feedback of the par-
ticipants was enthusiastic and motivated, although one more day 
would have been desirable to dig deeper into the context of the 
challenge and to transform the ideas into more realistic solutions. 
The workshop was a great experience for experts and young sci-
entists since it allowed cooperation in a novel and creative en-
vironment and brought new insights into the field of in silico 
methods.
We thank all supporters and helpers as well as the speakers/
experts and the participants who made the seminar and work-
shop a great success. 
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